文献速递胸部肿瘤

胸腺放射与NSCLC患者不良结局相关

Thymic radiation is associated with worse outcomes in patients with NSCLC.
PubMed 文献 · Ann Oncol · 2026-08-25

该多队列分析纳入1107例NSCLC患者,包括III期RTOG-0617试验和两个真实世界队列,使用深度学习系统量化胸腺功能,评估胸腺平均剂量与远处转移风险的关系。结果显示胸腺意外照射与远处转移风险增加独立相关,胸腺功能保留者风险更高,而胸腺功能受损者无此关联。

要点

  • 胸腺平均剂量每增加1 Gy,远处转移风险增加1.57%-4.21%。
  • 胸腺功能保留的患者接受胸腺照射后远处转移风险更高。
  • 胸腺保护性放疗计划可在不牺牲肿瘤覆盖和心肺约束下实现。

核心结论

  • 胸腺放射暴露与NSCLC患者远处转移和死亡风险增加独立相关,尤其在胸腺功能保留者中。

研究设计与样本

  • 多队列分析纳入1107例NSCLC患者,包括III期RTOG-0617试验(n=460)和两个真实世界队列:HARVARD-CRT(n=422)和HARVARD-DURVA(n=225)。
  • 使用深度学习系统评估胸腺影像特征作为胸腺功能的替代指标,以胸腺平均剂量衡量放射暴露。

主要发现

  • 胸腺平均剂量每增加1 Gy,远处转移风险增加1.57%-4.21%(RTOG-0617:aHR 1.29,P=0.0028;HARVARD-CRT:aHR 1.33,P=0.011;HARVARD-DURVA:aHR 1.95,P=0.007)。
  • 胸腺功能保留的患者接受放射后远处转移风险更高,而胸腺功能受损者无显著关联。
  • 随访1年影像显示胸腺功能剂量依赖性下降,循环淋巴细胞计数降低。

临床怎么用

  • 考虑将胸腺作为放疗中的感兴趣器官,探索胸腺保护策略以保留免疫健康。
  • 胸腺保护性放疗计划可在不 compromise 肿瘤覆盖和心肺约束的前提下实现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging evidence indicates the functional importance of the thymus in adult health and may influence oncological outcomes, yet current radiotherapy (RT) practice does not consider the thymus as an organ of interest. Because RT may incidentally expose the thymus to radiation, we hypothesized that thymic radiation dose is negatively associated with major clinical outcomes. PATIENTS AND METHODS: This multicohort analysis included 1107 patients with non-small-cell lung cancer (NSCLC), including the phase III RTOG-0617 trial (n = 460) and two independent real-world cohorts of patients treated with chemoradiotherapy alone (n = 422; HARVARD-CRT) or in combination with consolidation immunotherapy (n = 225; HARVARD-DURVA). We quantified thymic function using a deep learning system that assessed thymic radiographic characteristics as a proxy for thymic function. Mean thymic dose (MTD) was used to measure thymic radiation exposure. RESULTS: Incidental thymic irradiation was associated with increased risk of distant metastases after confounding adjustments. Concretely, a 1-Gy increase in MTD was associated with an increased distant metastasis risk of 1.57%-4.21% [RTOG-0617: adjusted hazard ratio (aHR) 1.29, P = 0.0028; HARVARD-CRT: aHR 1.33, P = 0.011; HARVARD-DURVA: aHR 1.95, P = 0.007]. In thymic health (TH)-stratified analysis, patients with preserved TH before RT appeared to be at particularly greater risk, whereas no associations emerged in patients with impaired TH. One-year follow-up imaging demonstrated dose-dependent declines in TH and lower circulating lymphocyte counts, consistent with a possible biological link between thymic irradiation and loss of immune competence. An exploratory feasibility study suggested that reoptimizing RT planning for thymic sparing can be achieved without compromising tumor coverage or cardiopulmonary constraints. CONCLUSIONS: Thymic radiation exposure was independently associated with higher risks of metastasis and death in patients with NSCLC, especially in those with preserved thymic function. These findings raise awareness toward considering the thymus as an organ of interest in RT and suggest that thymus-sparing strategies may help preserve immune health and improve patient outcomes.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Prudente V, Bernatz S, Pai S, et al. Thymic radiation is associated with worse outcomes in patients with NSCLC. Ann Oncol. 2026. PMID: 42641684. doi:10.1016/j.annonc.2026.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。